Dialyzable leukocyte extract suppresses the activity of essential transcription factors for HIV-1 gene expression in unstimulated MT-4 cells

Biochem Biophys Res Commun. 2000 Jul 14;273(3):1099-103. doi: 10.1006/bbrc.2000.3065.

Abstract

The human immunodeficiency virus type 1 (HIV-1) contains regulatory regions in its long terminal repeat (LTR) implicated in the control of viral gene expression. We previously demonstrated that Dialyzable Leukocyte Extract (DLE), a preparation derived from immune leukocytes, is able to inhibit HIV-1 replication in MT-4 cell cultures. Here, we examined the effect of DLE on the activation of NF-kappaB and Sp1 transcription factors. NF-kappaB activity was completely suppressed after seven days of treatment with 2.5 U/mL of DLE, with a parallel large reduction in the amounts of Sp1 complexes. These findings correlate with the maximum inhibitory effect on HIV-1 replication described in a previous report. IkappaBalpha and NF-kappaB p65(RelA) gene expression are not regulated by DLE in MT-4 cells. Although up to day, the precise molecular mechanism of DLE biological activity in HIV-1 infection remains unclear, this report presents data that indicate a potential downregulatory effect of DLE on HIV-1 gene expression.

MeSH terms

  • Base Sequence
  • Cell Line
  • DNA Primers
  • Gene Expression Regulation, Viral / physiology*
  • HIV-1 / genetics*
  • Humans
  • NF-kappa B / metabolism
  • Transcription Factors / physiology*
  • Transfer Factor / pharmacology*

Substances

  • DNA Primers
  • NF-kappa B
  • Transcription Factors
  • Transfer Factor